Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Neo Modulus has developed a broad portfolio of scaffold-based regenerative medical devices using advanced biomimetic manufacturing techniques. The company’s products support complex tissue regeneration and organ reconstruction across multiple clinical fields. It has more than 20 Class III implantable device programs in its pipeline with several already commercialized or close to market launch in China. The company collaborates with leading academic institutions globally to drive innovation in materials science and regenerative medicine
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neo Modulus.